#147 What place does IP Strategy have in Life Sciences and AI? with Kevin Buckley - Founder
Summary: <p>We have Kevin Buckley, Founder and CEO of Torrey Pines Law Group, PC in San Diego, USA. He joins us for an insightful chat on Life Sciences and AI.</p> <p>He created Torrey Pines Law Group when he returned home to San Diego in 2013. Throughout his career, he has successfully represented pharmaceutical, biopharmaceutical, medical device, biotechnology, specialty chemical, digital health, healthcare software, artificial intelligence, and convergence technology clients for more than 20 years.</p> <p><strong>Quotes:</strong></p> <ul> <li>"If you got a patent on something you can’t detect the infringement of, then why get a patent in the first place, maybe keep it trade secret or as a small subset of trade secret law. Early on you need to decide what you want to do."<br> </li> <li>"IP does not exist in a vacuum. IP affects so many different other areas of law, business and science to some degree. Also, different laws, business and science also impact IP law, so it is completely integrated with every other facet of law."<br> </li> </ul> <p>Thanks to our Sponsor</p> <p><a href="//talentinsights.com.au">Talent Insights Group</a></p> <p>Read the full episode summary here: <a href="//www.datafuturology.com/podcast/2021/3/17/what-place-does-ip-strategy-have-in-life-sciences-and-ai-with-kevin-buckley-founder">Ep 147</a></p> <p><strong>Enjoy the show!</strong></p> --- Send in a voice message: https://podcasters.spotify.com/pod/show/datafuturology/message
